Indorama Ventures Public Company (IVL) Q4 2024 earnings summary

Executive summary

• 2024 was a challenging year for the chemical industry, marked by global overcapacity, volatile macroeconomic conditions, and significant non-cash impairment charges.

• Management executed the IVL 2.0 transformation strategy, focusing on asset optimization, cost reduction, and digital transformation.

• Timely actions, including asset rationalization and operational efficiency, led to improved earnings and resilience, with reported EBITDA up 26% to $1.41B and adjusted EBITDA up 10% to $1.52B.

• Like-for-like volumes grew 4% year-over-year, supported by stable demand for end products.

• Reported a consolidated net loss of THB 19.2 billion for 2024, reflecting challenging market conditions and significant impairment charges.

Financial highlights

• Revenue for 2024 was $15,358M (THB 541.6 billion), nearly unchanged year-over-year.

• Reported EBITDA for 2024 was $1.4 billion, up 26% year-over-year; adjusted EBITDA reached $1.52 billion, up 10%.

• Cash flow from operations was $1.33 billion, with $110 million for one-time severance and $229 million for working capital due to supply chain disruptions.

• Net debt stood at $7 billion at year-end, with a net debt/equity ratio of 1.3x and DSCR of 1.32x.

• Significant impairment losses on long-lived assets of THB 22.5 billion recognized in 2024.

Outlook and guidance

• Management expects further fixed cost savings of $100 million in 2025 from ongoing rationalization.

• Asset rationalizations are expected to deliver $160–$170 million per annum in fixed cost reduction and $130–$140 million per annum EBITDA increase by 2025/2026.

• Working capital outflows are expected to normalize in 2025 as supply chains stabilize.

• Full-year benefits from asset rationalization and land sales ($150–$200 million) anticipated in 2025–2026.

• Packaging business IPO targeted for Q1 2026, aiming to raise $250 million.